Sparsentan DUET study looked at ~100 FSGS patients, and decreased proteinuria from the original 19% (on irbesarten) to 44% (average)
They described it as a 'two-fold' decrease.
I can't seem to find their actual data or results online.
Anyone help?
Dimerix vs Retrophin, page-38
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $217.5M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.5¢ | 38.0¢ | $444.0K | 1.151M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 7392 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |